Search in:

Advanced search

Clinical Ophthalmology Volume 11, 2017 - Issue

Submit an article Journal homepage

Open access

316

Views

CrossRef citations to date

Altmetric

Original Research

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

Kevin J Blinder1 The Retina Institute, St Louis, MOCorrespondence[email protected]

Pravin U Dugel2 Retinal Consultants of Arizona, Phoenix, AZ;3 USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles

Sanford Chen4 Orange County Retina, Santa Ana

J Michael Jumper5 West Coast Retina Medical Group, San Francisco

John G Walt6 Allergan plc, Irvine, CA, USA

David A Hollander6 Allergan plc, Irvine, CA, USA

Lanita C Scott6 Allergan plc, Irvine, CA, USA

show all

Pages 393-401 | Published online: 21 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ArevaloJFDiabetic macular edema: current management 2013World J Diabetes20134623123324379911
PubMedGoogle Scholar
American Diabetes AssociationStandards of medical care in diabetes – 2009Diabetes Care200932suppl 1S13S6119118286
PubMed Web of Science ®Google Scholar
BoyerDSHopkinsJJSorofJEhrlichJSAnti-vascular endothelial growth factor therapy for diabetic macular edemaTher Adv Endocrinol Metab20134615116924324855
PubMedGoogle Scholar
NguyenQDShahSMHeierJSREAD-2 Study GroupPrimary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) studyOphthalmology20091161121752181.e119700194
PubMed Web of Science ®Google Scholar
MitchellPBandelloFSchmidt-ErfurthURESTORE Study GroupThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
PubMed Web of Science ®Google Scholar
MichaelidesMKainesAHamiltonRDA prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2Ophthalmology2010117610781086.e220416952
PubMed Web of Science ®Google Scholar
BrownDMSchmidt-ErfurthUDoDVIntravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studiesOphthalmology2015122102044205226198808
PubMed Web of Science ®Google Scholar
SheaAMCurtisLHHammillBGResource use and costs associated with diabetic macular edema in elderly personsArch Ophthalmol2008126121748175419064859
PubMedGoogle Scholar
WallickCJHansenRNCampbellJKissSKowalskiJWSullivanSDComorbidity and health care resource use among commercially insured non-elderly patients with diabetic macular edemaOphthalmic Surg Lasers Imaging Retina201546774475126247456
PubMed Web of Science ®Google Scholar
NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
PubMed Web of Science ®Google Scholar
Diabetic Retinopathy Clinical Research NetworkWellsJAGlassmanARAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
PubMed Web of Science ®Google Scholar
WellsJAGlassmanARAyalaARDiabetic Retinopathy Clinical Research NetworkAflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trialOphthalmology201612361351135926935357
PubMed Web of Science ®Google Scholar
KissSLiuYBrownJClinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edemaClin Ophthalmol201481611162125210429
PubMedGoogle Scholar
HolekampNMLiuYYehWSClinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degenerationAm J Ophthalmol20141574825833.e124388973
PubMed Web of Science ®Google Scholar
VanderBeekBLShahNParikhPCMaLTrends in the care of diabetic macular edema: analysis of a national cohortPLoS One2016112e014945026909797
PubMed Web of Science ®Google Scholar
GregoriNZFeuerWRosenfeldPJNovel method for analyzing Snellen visual acuity measurementsRetina20103071046105020559157
PubMed Web of Science ®Google Scholar
LeeRWongTYSabanayagamCEpidemiology of diabetic retinopa-thy, diabetic macular edema and related vision lossEye Vis (Lond)201521726605370
PubMedGoogle Scholar
American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437suppl 1S14S8024357209
PubMed Web of Science ®Google Scholar
ChenRCheadleAJohnsonDDuranBUS trends in receipt of appropriate diabetes clinical and self-care from 2001 to 2010 and racial/ethnic disparities in careDiabetes Educ201440675676625142006
PubMed Web of Science ®Google Scholar
JiangSBarnerJCParkCLingYLTreatment patterns of anti-vascular endothelial growth factor and laser therapy among patients with diabetic macular edemaJ Manag Care Spec Pharm201521973574126308221
PubMed Web of Science ®Google Scholar
EhrlichRDanIDeitchIAxer-SiegelRMimouniKThe effectiveness of intravitreal ranibizumab in patients with diabetic macular edema who have failed to respond to intravitreal bevacizumabOphthalmologica2016235313313626926483
PubMed Web of Science ®Google Scholar
WileyHEThompsonDJBaileyCA crossover design for comparative efficacy: a 36-week randomized trial of bevacizumab and ranibizumab for diabetic macular edemaOphthalmology2016123484184926875003
PubMed Web of Science ®Google Scholar
BrownDMNguyenQDMarcusDMRIDE and RISE Research GroupLong-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDEOphthalmology2013120102013202223706949
PubMed Web of Science ®Google Scholar
MurakamiTNishijimaKAkagiTOptical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edemaInvest Ophthalmol Vis Sci20125331506151122323463
PubMed Web of Science ®Google Scholar
ZhangXZengHBaoSWangNGilliesMCDiabetic macular edema: new concepts in patho-physiology and treatmentCell Biosci201442724955234
PubMed Web of Science ®Google Scholar
DugelPUBandelloFLoewensteinADexamethasone intravitreal implant in the treatment of diabetic macular edemaClin Ophthalmol201591321133526213460
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date